Skip to content
Clinical Trials – home

Turku University Hospital

Verifiedinfo

Finland Kiinamyllynkatu 4-8, 20520 Turku, Finland

  • 84 trials recruiting
  • Non-small cell lung cancer · Prostate cancer · Ovarian cancer
  • Adults and children

About Specializations

Turku University Hospital in Turku, Finland specialises in clinical trials of conditions such as Non-small cell lung cancer, Prostate cancer, Ovarian cancer, Endometrial cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases at Turku University Hospital

Clinical research at this Heart Center focuses on cardiovascular diseases, with a strong emphasis on coronary artery disease. The studies are designed to evaluate better treatment options for people undergoing percutaneous coronary intervention, especially those who may face a higher bleeding risk.

  • Comparing drug-coated balloons with drug-eluting stents for coronary artery disease
  • Studying treatment approaches for patients with acute coronary syndromes
  • Assessing care strategies for patients at increased bleeding risk

These trials aim to improve the safety and effectiveness of heart disease treatment while supporting more personalized decisions about antiplatelet therapy and device-based care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kiinamyllynkatu 4-820520 TurkuFinland
Recruiting now
84 trials
Conditions studied
142
Partner status
Verified

More sites in TurkuFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

207 clinical trials

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Bronchiectasis

Recruiting
Investigational
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Crohn's disease

Recruiting
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FinlandFinland
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:VOTOPLAM
  • Sponsor:Novartis Pharma AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.